| Common polygenic variation enhances risk prediction for Alzheimer’s disease V Escott-Price, R Sims, C Bannister, D Harold, M Vronskaya, E Majounie, ... Brain 138 (12), 3673-3684, 2015 | 429 | 2015 |
| Can people with type 2 diabetes live longer than those without? A comparison of mortality in people initiated with metformin or sulphonylurea monotherapy and matched, non … CA Bannister, SE Holden, S Jenkins‐Jones, CL Morgan, JP Halcox, ... Diabetes, Obesity and Metabolism 16 (11), 1165-1173, 2014 | 422 | 2014 |
| Enzyme replacement improves survival among patients with pancreatic cancer: Results of a population based study KJ Roberts, CA Bannister, H Schrem Pancreatology 19 (1), 114-121, 2019 | 107 | 2019 |
| The role of idioms in sentiment analysis L Williams, C Bannister, M Arribas-Ayllon, A Preece, I Spasić Expert Systems with Applications 42 (21), 7375-7385, 2015 | 107 | 2015 |
| External validation of the UKPDS risk engine in incident type 2 diabetes: a need for new type 2 diabetes–specific risk equations CA Bannister, CD Poole, S Jenkins-Jones, CL Morgan, G Elwyn, I Spasić, ... Diabetes care 37 (2), 537-545, 2014 | 59 | 2014 |
| Disentangling the biological pathways involved in early features of Alzheimer's disease in the Rotterdam Study S Ahmad, C Bannister, SJ van der Lee, D Vojinovic, HHH Adams, ... Alzheimer's & Dementia 14 (7), 848-857, 2018 | 39 | 2018 |
| Risk of cardiovascular events, arrhythmia and all-cause mortality associated with clarithromycin versus alternative antibiotics prescribed for respiratory tract infections: a … E Berni, H de Voogd, JP Halcox, CC Butler, CA Bannister, ... BMJ open 7 (1), e013398, 2017 | 26 | 2017 |
| Natural history of patients taking rifaximin-α for recurrent hepatic encephalopathy and risk of future overt episodes and mortality: a post-hoc analysis of clinical trials data CA Bannister, JG Orr, AV Reynolds, M Hudson, P Conway, A Radwan, ... Clinical Therapeutics 38 (5), 1081-1089. e4, 2016 | 22 | 2016 |
| Estimation of health-related utility (EQ-5D index) in subjects with seasonal allergic rhinoconjunctivitis to evaluate health gain associated with sublingual grass allergen … CD Poole, CA Bannister, JN Andreasen, JS Andersen, CJ Currie Health and quality of life outcomes 12 (1), 99, 2014 | 19 | 2014 |
| A genetic programming approach to development of clinical prediction models: A case study in symptomatic cardiovascular disease CA Bannister, JP Halcox, CJ Currie, A Preece, I Spasić PLoS One 13 (9), e0202685, 2018 | 14 | 2018 |
| The development and application of a chairside oral health risk and need stratification tool in general dental services AL Cope, C Bannister, A Karki, P Harper, M Allen, R Jones, S Peddle, ... Journal of Dentistry 123, 104206, 2022 | 3 | 2022 |
| PWE-153 cost effectiveness of Rifaximin-a in the reduction of recurrence of overt hepatic encephalopathy CD Poole, P Conway, K Nanuwa, B Joseph, C Bannister, CJ Currie Gut 63 (Suppl 1), A191-A192, 2014 | 3 | 2014 |
| Time to complete contemporary dental procedures–estimates from a cross-sectional survey of the dental team C Bannister, AL Cope, A Karki, P Harper, S Peddle, B Walters, M Allen, ... BMC Oral Health 23 (1), 926, 2023 | 2 | 2023 |
| P0139: Patients experiencing repeated episodes of hepatic encephalopathy have increasing risk of death. A post HOC analysis of rifaximin-α open label study data CA Bannister, P Conway, A Radwan, CL Morgan, E Berni, CJ Currie Journal of Hepatology, S353-S354, 2015 | 2 | 2015 |
| PWE-154 the first evaluation of the relationship between the chronic liver disease questionnaire and the Eq-5d index in hepatic encephalopathy patients treated with rifaximin-a E Berni, C Bannister, CD Poole, P Conway, K Nanuwa, CJ Currie Gut 63, A192, 2014 | 2 | 2014 |
| Automatic development of clinical prediction models with genetic programming: A case study in cardiovascular disease CA Bannister, CJ Currie, A Preece, I Spasic Value in Health 17 (3), A200-A201, 2014 | 2 | 2014 |
| Orals: validation of UKPDS risk engine predictions among patients with type 2 diabetes routinely managed in UK primary care C Bannister, CD Poole, S Jenkins-Jones, CL Morgan, C Currie, G Elwyn Diabetes 62 (Supp 1), A71-A71, 2013 | 2 | 2013 |
| Real-world evidence from the first online healthcare analytics platform—Livingstone. Validation of its descriptive epidemiology module BR Heywood, CL Morgan, TR Berni, DR Summers, BI Jones, ... PLOS Digital Health 2 (7), e0000310, 2023 | 1 | 2023 |
| Can people with type 2 diabetes live longer than people without diabetes? A comparison of all-cause mortality in people initiated with metformin monotherapy or sulfonylurea … CA Bannister, SE Holden, S Jenkins-Jones, CL Morgan, JP Halcox, ... Diabetes, Obesity and Metabolism 16 (11), 1165-1173, 2014 | 1 | 2014 |
| Mortality after cancer among patients with diabetes mellitus: effect of diabetes duration and treatment:(questionable) classification of diabetic patients based on combination … SE Holden, CA Bannister, CJ Currie Diabetologia 57, 2001-2002, 2014 | 1 | 2014 |
Irena SpasicProfessor in Computer Science, Cardiff UniversityVerified email at cs.cardiff.ac.uk
